Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Diabetes mellitus (DM) and tuberculosis (TB) are two common diseases with increasing geographic overlap and clinical interactions. The effect of DM and hemoglobin A1c (HbA1c) values on the pharmacokinetics (PK) and pharmacodynamics (PD) of anti-TB drugs remains poorly characterized. Newly diagnosed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Alfarisi, Omamah, Mave, Vidya, Gaikwad, Sanjay, Sahasrabudhe, Tushar, Ramachandran, Geetha, Kumar, Hemanth, Gupte, Nikhil, Kulkarni, Vandana, Deshmukh, Sona, Atre, Sachin, Raskar, Swapnil, Lokhande, Rahul, Barthwal, Madhusudan, Kakrani, Arjun, Chon, Sandy, Gupta, Amita, Golub, Jonathan E., Dooley, Kelly E.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201087/
https://ncbi.nlm.nih.gov/pubmed/30126955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01383-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars